United Therapeutics | Beneficio Operativo



Operating Profit Cambio Fecha
Amarin USD -25168000 24.64M 2024-09
Ardelyx USD 8.12M 5.89M 2024-12
Baxter International USD -435000000 590M 2024-12
Bayer EUR 3.53B 7.35B 2024-12
Biogen USD 311.2M 130.2M 2025-03
BioMarin Pharmaceutical USD 223.89M 62.49M 2025-03
Gilead Sciences USD 2.24B 215M 2025-03
GlaxoSmithKline GBP 2.22B 1.52B 2025-03
Halozyme Therapeutics USD 141.54M 33.97M 2025-03
Insmed USD -230414000 16.98M 2024-12
Ionis Pharmaceuticals USD -146000000 35.18M 2025-03
J&J USD 13.63B 9.74B 2025-03
Moderna USD -1050000000 196M 2025-03
Pfizer USD 3.67B 4.08B 2025-03
PTC Therapeutics USD 970.22M 1.03B 2025-03
Regeneron Pharmaceuticals USD 591.7M 398.5M 2025-03
Sarepta Therapeutics USD -300386000 462.07M 2025-03
Teva Pharmaceutical Industries USD 455M 506M 2024-12
United Therapeutics USD 382.8M 25.1M 2025-03
Vertex Pharmaceuticals USD 1.03B 90.3M 2024-12



United Therapeutics Beneficio Operativo - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - May 2025.